Form 4 for CL Colgate-Palmolive
Accepted 2022-05-11 00:00:00 ET · period of report 2022-05-09 · accession 0001225208-22-006880 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-11 | 2022-05-09 | CL | BILBREY JOHN P | Dir | A - Grant | $0.00 | +2,317 | 24.6K | +10% | $0 |
| D | 2022-05-11 | 2022-05-09 | CL | BILBREY JOHN P | Dir | A - Grant | $0.00 | +3,122 | 3,122 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-09 | A | A | 2,317 | $0.00 | 24,565 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-05-09 | A | A | 3,122 | $0.00 | 3,122 | D | $77.67 · — to 2030-05-09 | 3,122 Common Stock | (F3) Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 9, 2022 grant date. |